Heart healing hope: new drug targets scarring in diabetic kidney patients
Disease control
ENROLLING_BY_INVITATION
This study tests whether a daily pill called finerenone can reduce fat and scarring in the heart muscle of people with diabetic kidney disease and heart failure. About 40 adults will take the drug for 6 months and get advanced heart scans to measure changes. The goal is to see if…
Phase: PHASE4 • Sponsor: Cathay General Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC